shopping cart
nothing in cart
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
about us
upcoming events
Oct 18th - AFCC-O 10th Anniversary Conference | The Future of Youth: Moving Beyond Risk to Resilience [Association of Family and Conciliation Courts Ontario Chapter]
Oct 19th - 20th Annual Canadian Energy Psychology Conference: Emerging Strategies for Mind-Body-Spirit Integration [The Canadian Association for Integrative and Energy Therapies (CAIET)]
Oct 19th - Rewiring Your Practice: Essential Clinical Applications of Polyvagal Theory [Leading Edge Seminars]
Oct 19th - The Awakening: Clearmind's Introductory Workshop [Clearmind International Institute]
Oct 22nd - 65th annual meeting of the American Academy of Child & Adolescent Psychiatry, Seattle, WA [AACAP]
schools agencies and other institutional orders (click here)
Cannabinoids and the Brain
Parker, Linda A.
MIT Press / Softcover / 2017-03-01 / 0262035790
Cannabis / Addiction
price: $46.95
In Stock (Ships within one business day)

The cannabis plant has been used for recreational and medicinal purposes for more than 4,000 years, but the scientific investigation into its effects has only recently yielded useful results. In this book, Linda Parker offers a review of the scientific evidence on the effects of cannabinoids on brain and behavioral functioning, with an emphasis on potential therapeutic uses.

Parker describes the discovery of tetrahydocannbinol (THC), the main psychoactive component of cannabis, and the further discovery of cannabinoid receptors in the brain. She explains that the brain produces chemicals similar to THC, which act on the same receptors as THC, and shows that the endocannabinoid system is involved in all aspects of brain functioning. Parker reports that cannabis contains not only the psychoactive compound THC, but also other compounds of potential therapeutic benefit, and that one of them, cannabidiol (CBD), shows promise for the treatment of pain, anxiety, and epilepsy. Parker reviews the evidence on cannabinoids and anxiety, depression, mood, sleep, schizophrenia, learning and memory, addiction, sex, appetite and obesity, chemotherapy-induced nausea, epilepsy, and such neurodegenerative disorders as multiple sclerosis and Alzheimer’s Disease. Each chapter also links the scientific evidence to historical and anecdotal reports of the medicinal use of cannabis.

As debate about the medical use of marijuana continues, Parker’s balanced and objective review of the fundamental science and potential therapeutic effects of cannabis is especially timely.


“Linda Parker is recognized by many of her academic peers as an eminent cannabinoid scientist. The book provides a great read both for those who already possess some, or even a lot of scientific and clinical knowledge about the central effects of cannabis and cannabinoids, and for those who are keen to begin gathering such knowledge.”
—Roger Pertwee, Professor, University of Aberdeen, Scotland; cannabinoid pharmacologist; editor of Handbook of Cannabis and Endocannabinoids

“This book, written by a superb scientist with decades of experience in the field of endocannabinoids, is an elegant synthesis of a vast literature that has become a hot topic in medicine. It is written in language that is accessible to all and will be engaging for the curious layperson as well as scientists with background and expertise in the cannabinoid field. When medical schools finally catch on that the endocannabinoid system is a critical part of the human immune and pain defense network, this will also serve as a perfect reference text for medical trainees at all levels.”
—Mary Lynch, Professor, Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University

“Parker’s book is a pleasure to behold—a treasure trove of knowledge from a much-admired authority in the field of cannabis research. Parker provides a cornucopia of cannabinoid insights for the novice and expert alike: a compact yet richly detailed account of one of the fastest-moving frontiers in science and medicine. Eleven out of ten!”
—Iain McGregor, Professor of Psychopharmacology, University of Sydney; Director of Preclinical Research, Lambert Initiative for Cannabinoid Therapeutics

About the Author:

Linda A. Parker is Professor in the Psychology and Collaborative Neuroscience Program and Canada Research Chair in Behavioural Neuroscience at the University of Guelph. She was the 2016 recipient of the Lifetime Achievement Award from the International Cannabinoid Research Society and is currently President of the Canadian Consortium for Investigation of Cannabinoids.

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2014

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
Hours: 9-6 M-W / 9-7 Th-F / 10-6 Sat / 12-5 Sun EST

Click here to read previous issues.
related events
List for OPA Addiction 101
OPA Addiction 101 Day
The Cannabis Primer: What You Need to Know....NOW!
other lists
MIT Press